These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 7518029)
1. Differential influence of haloperidol and sulpiride on dopamine receptors and peptide mRNA levels in the rat striatum and pituitary. Jaber M; Tison F; Fournier MC; Bloch B Brain Res Mol Brain Res; 1994 Apr; 23(1-2):14-20. PubMed ID: 7518029 [TBL] [Abstract][Full Text] [Related]
2. Differential regulation of glutamate decarboxylase and preproenkephalin mRNA levels in the rat striatum. Soghomonian JJ Brain Res; 1994 Mar; 640(1-2):146-54. PubMed ID: 8004444 [TBL] [Abstract][Full Text] [Related]
3. Effects of selective D1- or D2-like dopamine receptor antagonists with acute "binge" pattern cocaine on corticotropin-releasing hormone and proopiomelanocortin mRNA levels in the hypothalamus. Zhou Y; Spangler R; Yuferov VP; Schlussmann SD; Ho A; Kreek MJ Brain Res Mol Brain Res; 2004 Nov; 130(1-2):61-7. PubMed ID: 15519677 [TBL] [Abstract][Full Text] [Related]
4. Differential regulation of mRNA levels encoding for the two isoforms of glutamate decarboxylase (GAD65 and GAD67) by dopamine receptors in the rat striatum. Laprade N; Soghomonian JJ Brain Res Mol Brain Res; 1995 Dec; 34(1):65-74. PubMed ID: 8750862 [TBL] [Abstract][Full Text] [Related]
5. Muscarinic receptors regulate striatal neuropeptide gene expression in normal and amphetamine-treated rats. Wang JQ; McGinty JF Neuroscience; 1996 Nov; 75(1):43-56. PubMed ID: 8923522 [TBL] [Abstract][Full Text] [Related]
6. Regulation of the pro-opiomelanocortin mRNA levels in rat pituitary by dopaminergic compounds. Chen CL; Dionne FT; Roberts JL Proc Natl Acad Sci U S A; 1983 Apr; 80(8):2211-5. PubMed ID: 6572972 [TBL] [Abstract][Full Text] [Related]
7. Reduction of dopamine receptor activity differentially alters striatal neuropeptide mRNA levels. Angulo JA; Christoph GR; Manning RW; Burkhart BA; Davis LG Adv Exp Med Biol; 1987; 221():385-91. PubMed ID: 3434462 [TBL] [Abstract][Full Text] [Related]
8. Differential effects on D2 dopamine receptor and prolactin gene expression by haloperidol and aripiprazole in the rat pituitary. Inoue A; Seto M; Sugita S; Hide I; Hirose T; Koga N; Kikuchi T; Nakata Y Brain Res Mol Brain Res; 1998 Apr; 55(2):285-92. PubMed ID: 9582438 [TBL] [Abstract][Full Text] [Related]
9. GABAergic modulation of striatal peptide expression in rats and the alterations induced by dopamine antagonist treatment. Jolkkonen J; Jenner P; Marsden CD Neurosci Lett; 1994 Oct; 180(2):273-6. PubMed ID: 7535410 [TBL] [Abstract][Full Text] [Related]
10. The effects of haloperidol on dopamine receptor gene expression. Fox CA; Mansour A; Watson SJ Exp Neurol; 1994 Dec; 130(2):288-303. PubMed ID: 7867758 [TBL] [Abstract][Full Text] [Related]
11. Adaptive changes in rat striatal preproenkephalin expression and dopamine-opioid interactions upon chronic haloperidol treatment during different developmental stages. De Vries TJ; Jonker AJ; Voorn P; Mulder AH; Schoffelmeer AN Brain Res Dev Brain Res; 1994 Apr; 78(2):175-81. PubMed ID: 7913003 [TBL] [Abstract][Full Text] [Related]
12. SCH 58261, a selective adenosine A2A receptor antagonist, decreases the haloperidol-enhanced proenkephalin mRNA expression in the rat striatum. Wardas J; Pietraszek M; Dziedzicka-Wasylewska M Brain Res; 2003 Jul; 977(2):270-7. PubMed ID: 12834887 [TBL] [Abstract][Full Text] [Related]
13. Differential regulation of neuropeptide mRNA expression in intrastriatal striatal transplants by host dopaminergic afferents. Campbell K; Wictorin K; Björklund A Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10489-93. PubMed ID: 1438238 [TBL] [Abstract][Full Text] [Related]
14. Effects of risperidone and haloperidol on tachykinin and opioid precursor peptide mRNA levels in the caudate-putamen and nucleus accumbens of the rat. Mijnster MJ; Schotte A; Docter GJ; Voorn P Synapse; 1998 Apr; 28(4):302-12. PubMed ID: 9517839 [TBL] [Abstract][Full Text] [Related]
15. Effect of long-term treatment with haloperidol and sulpiride on different types of dopaminergic receptors. Trabucchi M; Memo M; Battaini F; Reggiani A; Spano PF Adv Biochem Psychopharmacol; 1980; 24():275-81. PubMed ID: 7405667 [No Abstract] [Full Text] [Related]
16. Reserpine treatment stimulates enkephalin and D2 dopamine receptor gene expression in the rat striatum. Jaber M; Fournier MC; Bloch B Brain Res Mol Brain Res; 1992 Oct; 15(3-4):189-94. PubMed ID: 1331675 [TBL] [Abstract][Full Text] [Related]
17. Chronic treatment with haloperidol modifies the sensitivity of autoreceptors that modulate dopamine release in rat striatum. Yamada S; Yokoo H; Nishi S Eur J Pharmacol; 1993 Feb; 232(1):1-6. PubMed ID: 8458389 [TBL] [Abstract][Full Text] [Related]
18. Striatal neurons express increased level of dopamine D2 receptor mRNA in response to haloperidol treatment: a quantitative in situ hybridization study. Bernard V; Le Moine C; Bloch B Neuroscience; 1991; 45(1):117-26. PubMed ID: 1754061 [TBL] [Abstract][Full Text] [Related]
19. Differential regulation of striatal preproenkephalin mRNA by D1 and D2 dopamine receptors. Pollack AE; Wooten GF Brain Res Mol Brain Res; 1992 Jan; 12(1-3):111-9. PubMed ID: 1312196 [TBL] [Abstract][Full Text] [Related]
20. Differential effects of continuous administration for 1 year of haloperidol or sulpiride on striatal dopamine function in the rat. Rupniak NM; Mann S; Hall MD; Fleminger S; Kilpatrick G; Jenner P; Marsden CD Psychopharmacology (Berl); 1984; 84(4):503-11. PubMed ID: 6441951 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]